Skip to main content
Beginner 6 min read

WHO and IARC: how substances get labeled cancer-causing

The International Agency for Research on Cancer is the WHO's cancer agency. Here is what IARC does, what a classification means, and what it cannot tell you.

Source:International Agency for Research on Cancer (WHO) — About IARC and Agents Classified by the IARC Monographs

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

IARC is the specialized cancer agency of the World Health Organization, based in Lyon, France. Its Monographs programme reviews the evidence on whether agents can cause cancer and sorts them into groups. Those groups describe hazards for populations, not risk for one person.

  • IARC is the specialized cancer agency of the World Health Organization, headquartered in Lyon, France.

  • Its stated mission is cancer research for cancer prevention.

  • The IARC Monographs are titled Monographs on the Identification of Carcinogenic Hazards to Humans, and identification of hazards is what they do.

  • Through volumes 1 to 142, agents are sorted into Group 1, Group 2A, Group 2B, and Group 3.

Choose how you want to read this

The whole article, with every detail and caution.

This page is for patients and caregivers who have seen a news story saying something "causes cancer." It explains what IARC is, what its labels mean, and what they cannot tell you.

Who IARC actually is

The International Agency for Research on Cancer is the specialized cancer agency of the World Health Organization. It sits in Lyon, France. It has been working since 1965.

Its own short summary of its mission is: cancer research for cancer prevention.

IARC does several kinds of work. It runs research programmes. It publishes, including the WHO Classification of Tumours, the Monographs, and handbooks of cancer prevention. It also offers training and postdoctoral fellowships.

For most patients, though, one part of IARC is the part they have heard of.

The Monographs programme

The full title is worth reading slowly: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.

Every important limitation is already in that title. It says identification. It says hazards. It does not say risk. It does not say danger.

The programme reviews published evidence on an agent and reaches a classification. Agents can be chemicals, mixtures, occupations, or particular exposures. The results are published as monographs. Volumes have been appearing for decades.

The four groups

Across volumes 1 to 142, agents are sorted into four groups.

  • Group 1, carcinogenic to humans: 135 agents
  • Group 2A, probably carcinogenic to humans: 98 agents
  • Group 2B, possibly carcinogenic to humans: 329 agents
  • Group 3, not classifiable as to its carcinogenicity to humans: 498 agents

The formal definitions of these groups are set out in the Monographs Preamble.

Here is the part news coverage usually loses. The group tells you how confident the working group was that the agent can cause cancer. It does not tell you how much cancer any real-world exposure produces. Two Group 1 agents can differ enormously in how much they matter in ordinary life.

IARC is also careful about the edges of its own list. It strongly recommends consulting the complete monograph, its publication date, and the list of studies considered. That is because significant new information might support a different classification. And it says directly that for agents that have not been classified, no determination of non-carcinogenicity or overall safety should be inferred.

Counts are for volumes 1 to 142 and change as new volumes are published.

What IARC can do for you today

It can give you a stable reference point. Say a headline claims a substance causes cancer. You can look up whether IARC has evaluated it and which group it landed in.

It can show you the reasoning, not just the label. A monograph records the studies considered and when they were considered. So you can see the basis of a classification rather than taking a summary on faith.

It can put your reading in context. IARC classifies hazards worldwide. Its lists include occupational exposures, infections, and everyday agents side by side. That makes it easier to see that "on the list" covers a very wide range of real-world importance.

It can also help you feel less alone in the confusion. Maybe you have read one article saying something is safe and another saying it is a carcinogen. The classification system explains how both writers could be looking at the same evidence.

What IARC cannot do

It cannot tell you your own risk. A classification is not a personal risk estimate. It does not account for how much you were exposed to, when, or for how long.

It cannot explain your diagnosis. No classification can trace one person's cancer to one cause.

It cannot regulate. IARC produces evidence for policy. Setting exposure limits, warning labels, and bans is the job of governments and regulatory agencies. It cannot certify anything as safe. The absence of a classification means the question has not been settled there. It does not mean the answer is no.

And it cannot help with your treatment. It is a research agency, and nothing in a monograph speaks to your treatment plan. For questions about your care, call your care team.

Reading a classification calmly

Maybe you are here after seeing a warning about food, a product, or a job you once held. Try separating two questions.

The first is what the evidence says an agent can do. That is what IARC answers.

The second is what it means for you, given your actual life and exposure. People who know your history answer that question, not a group label.

Both questions are reasonable. Only the second one belongs in an exam room, and it is a fair thing to raise there.

A researcher in a lab coat and gloves uses a pipette at a laboratory bench
Laboratory testing. Photo: Rhoda Baer, National Cancer Institute (Public domain), via Wikimedia Commons.

Common questions

What is IARC?

The International Agency for Research on Cancer, the specialized cancer agency of the World Health Organization. It is based in Lyon, France, and its mission is cancer research for cancer prevention.

What are the classification groups?

Group 1 is carcinogenic to humans, Group 2A is probably carcinogenic to humans, Group 2B is possibly carcinogenic to humans, and Group 3 is not classifiable as to its carcinogenicity to humans. Definitions for the groups are set out in the Monographs Preamble.

Does Group 1 mean something is more dangerous than Group 2A?

Not in the sense most people assume. The groups describe how strong the evidence is that something can cause cancer, not how much cancer a given exposure causes. IARC's programme is described as identifying carcinogenic hazards.

How many agents have been classified?

Through volumes 1 to 142, IARC lists 135 agents in Group 1, 98 in Group 2A, 329 in Group 2B, and 498 in Group 3.

If something is not on the list, is it safe?

No. IARC states that for agents that have not been classified, no determination of non-carcinogenicity or overall safety should be inferred.

Can a classification change?

Yes. IARC strongly recommends consulting the complete monograph, its publication date, and the studies considered, and notes that significant new information might support a different classification.

Does IARC regulate anything?

No. It is a research agency. Its role includes producing evidence to inform cancer control policies, but decisions about laws and exposure limits belong to national governments and regulators.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Prepared by Cancer Explained's AI-assisted editorial system

Written from International Agency for Research on Cancer (WHO) — About IARC and Agents Classified by the IARC Monographs material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-09-03 what this meansLast updated: 2026-10-16Next planned review: 2027-09-03

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.